12:00 AM
 | 
Oct 04, 1999
 |  BC Week In Review  |  Company News  |  Deals

Neurocrine, DuPont, Janssen Pharmaceutica N.V. deal

NBIX and Janssen extended for two years a 1995 collaboration to identify corticotropin releasing factor (CRF) antagonists to treat psychiatric disorders. NBIX will receive additional research funding plus an upfront payment, milestones...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >